Engineers Gate Manager LP Purchases 28,451 Shares of Intuitive Surgical, Inc. $ISRG

Engineers Gate Manager LP boosted its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 509.1% in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 34,040 shares of the medical equipment provider’s stock after purchasing an additional 28,451 shares during the quarter. Engineers Gate Manager LP’s holdings in Intuitive Surgical were worth $13,537,000 at the end of the most recent quarter.

Other institutional investors have also recently bought and sold shares of the company. Motiv8 Investments LLC acquired a new position in shares of Intuitive Surgical during the fourth quarter valued at about $34,000. Main Street Group LTD acquired a new stake in shares of Intuitive Surgical in the 1st quarter worth about $30,000. MidAtlantic Capital Management Inc. bought a new position in Intuitive Surgical in the 4th quarter valued at about $39,000. Vermillion Wealth Management Inc. lifted its position in Intuitive Surgical by 58.1% in the 1st quarter. Vermillion Wealth Management Inc. now owns 68 shares of the medical equipment provider’s stock valued at $31,000 after acquiring an additional 25 shares in the last quarter. Finally, High Note Wealth LLC boosted its stake in Intuitive Surgical by 50.0% during the 4th quarter. High Note Wealth LLC now owns 69 shares of the medical equipment provider’s stock valued at $39,000 after purchasing an additional 23 shares during the last quarter. Institutional investors and hedge funds own 83.64% of the company’s stock.

Insider Activity at Intuitive Surgical

In other Intuitive Surgical news, EVP Gary Loeb sold 400 shares of Intuitive Surgical stock in a transaction dated Monday, August 10th. The shares were sold at an average price of $379.00, for a total value of $151,600.00. Following the sale, the executive vice president owned 5,320 shares of the company’s stock, valued at approximately $2,016,280. The trade was a 6.99% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Mark Brosius sold 77 shares of the business’s stock in a transaction dated Friday, August 21st. The shares were sold at an average price of $375.57, for a total transaction of $28,918.89. Following the completion of the transaction, the executive vice president owned 881 shares in the company, valued at approximately $330,877.17. The trade was a 8.04% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 11,256 shares of company stock valued at $4,475,079 over the last quarter. Corporate insiders own 0.60% of the company’s stock.

Intuitive Surgical Trading Up 2.0%

Shares of ISRG opened at $360.46 on Friday. The stock has a 50 day moving average of $377.41 and a 200 day moving average of $424.21. The company has a market capitalization of $127.34 billion, a price-to-earnings ratio of 41.29, a PEG ratio of 2.67 and a beta of 1.47. Intuitive Surgical, Inc. has a 12 month low of $328.57 and a 12 month high of $603.88.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings data on Thursday, July 16th. The medical equipment provider reported $2.80 earnings per share for the quarter, topping the consensus estimate of $2.48 by $0.32. The business had revenue of $2.89 billion for the quarter, compared to analysts’ expectations of $2.83 billion. Intuitive Surgical had a return on equity of 16.91% and a net margin of 28.45%.The business’s revenue was up 18.4% on a year-over-year basis. During the same quarter in the previous year, the firm earned $1.81 earnings per share. As a group, equities research analysts predict that Intuitive Surgical, Inc. will post 8.85 earnings per share for the current year.

More Intuitive Surgical News

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: A meta-analysis found that da Vinci robotic-assisted surgery produced statistically significant improvements across 13 common benign conditions, including shorter hospital stays and faster returns to work versus laparoscopic and open surgery. The results reinforce the clinical value of Intuitive’s platform and could support further hospital adoption. Intuitive reports positive meta-analysis data
• Positive Sentiment: BTIG reiterated its Buy rating and set a $469 price target, signaling considerable potential upside. Broader analyst coverage remains favorable, with the stock described as trading at its cheapest valuation in roughly a decade. Recent earnings also showed strong execution, including 18.4% year-over-year revenue growth and an earnings beat. BTIG reiterates Buy rating
• Neutral Sentiment: Intuitive Surgical presented at the Wells Fargo Healthcare Conference. Investors are focused on management’s commentary regarding procedure trends, guidance, competition, costs and the long-term opportunity for robotic surgery. Wells Fargo Healthcare Conference transcript
• Neutral Sentiment: Reported short-interest data showed zero shares and a zero-day short-interest ratio, suggesting no measurable short positioning in the supplied data; however, the figures appear anomalous and should not be treated as a meaningful trading signal.
• Negative Sentiment: EVP Mark Brosius disclosed sales totaling 69 shares at approximately $350.20 and $361.23 under a pre-arranged Rule 10b5-1 plan. The transactions are small relative to his remaining holdings and are not necessarily bearish, but continued insider selling provides little additional support for the shares. Intuitive Surgical EVP stock sale
• Negative Sentiment: Investors remain concerned about slower U.S. procedure growth, rising costs, competitive pressure and the possibility that GLP-1 drugs could affect procedure volumes. Options markets also indicate that substantial volatility may persist after the stock’s steep decline from its 52-week high. ISRG volatility outlook

Analysts Set New Price Targets

ISRG has been the subject of a number of recent research reports. Wall Street Zen lowered Intuitive Surgical from a “buy” rating to a “hold” rating in a report on Saturday, August 15th. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Intuitive Surgical in a research report on Friday, August 14th. JPMorgan Chase & Co. decreased their price target on Intuitive Surgical from $550.00 to $450.00 and set an “overweight” rating for the company in a report on Friday, July 17th. Evercore set a $430.00 price target on Intuitive Surgical in a research report on Monday, July 6th. Finally, BTIG Research reaffirmed a “buy” rating and set a $469.00 price objective on shares of Intuitive Surgical in a report on Tuesday. Twenty-two equities research analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat, Intuitive Surgical currently has a consensus rating of “Moderate Buy” and an average target price of $508.68.

Intuitive Surgical Profile

Intuitive Surgical, Inc is a medical technology company that develops and manufactures robotic-assisted surgical systems and related products. Its technology is designed to support surgeons during minimally invasive procedures by providing enhanced visualization, instrument control and dexterity.

The company’s principal product is the da Vinci Surgical System, which is used across a range of specialties, including general surgery, urology, gynecology, cardiothoracic surgery and other procedures.